NIH-funded research NIH-funded research

3D imaging and machine learning to map cancer cell and immune cell interactions

Official title: 3D highly-multiplexed imaging and machine learning for immunoprofiling of human and murine tumors

Funded at Harvard Medical School · NIH-11446550 · Data updated 2026-11-12

A cancer-focused project uses advanced 3D imaging and AI to map how tumor cells and immune cells interact, helping doctors understand tumors better.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionHarvard Medical School
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 5, 2026
Project endJuly 31, 2031
Funding year2026
Award (this year)$194,804
NIH project number1R50CA305002-01A1
Project IDNIH-11446550 on NIH RePORTER

Who could benefit from this research

Could help

Patients with cancer whose tumors are studied or whose tissue samples could be analyzed using the imaging and data methods developed.

Less likely to help

Patients not contributing tumor tissue or not undergoing diagnostics tied to this imaging approach may not directly benefit.

What this research studies

This project leverages highly multiplexed 3D tissue imaging to examine human and mouse tumor samples in their natural environment. It combines advanced microscopy with machine learning to turn complex images into precise, single-cell data that describe tumor phenotypes and immune interactions. By supporting investigators and trainees, it aims to accelerate discovery in cancer biology and pave the way for more precise diagnostics and therapies. The work is anchored in Harvard Medical School's microscopy and computer vision core, with a network across multiple institutions to share tools and methods.

Why it matters

Potential benefit: If successful, patients could benefit from more detailed tumor profiling that informs personalized diagnostics and treatment strategies.

How similar studies have gone: Other studies in high-dimensional tissue imaging and AI-based image analysis have shown promise in better characterizing tumor biology and microenvironments.

Where this research is happening

  • Harvard Medical School
    Boston, United States
    Active

Researchers

  • Principal investigator: Yapp, Clarence H — Harvard Medical School
  • Study coordinator: Yapp, Clarence H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.